Cancer Family
Neoplasm
CI-CAN-00000001Explore in graph →
Non-malignant22,971 active trials259 approved drugs4,031 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000001Explore in graph →
Clinical trials
105,884 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04812743 | Colorectal Health Research Champions | terminated | N/A | 91 | Virginia Commonwealth UniversityOTHER | 1 | Feb 13, 2024 | clinicaltrials |
| NCT04297332 | Episodic Future Thinking and Future Thinking Priming for Smoking Cessation | terminated | N/A | 26 | Roswell Park Cancer InstituteOTHER | 1 | Feb 8, 2024 | clinicaltrials |
| NCT04779489 |
| Checkpoint Inhibitor and Radiation Therapy in Bulky, Node-Positive Bladder Cancer(CIRTiN-BC) |
| terminated |
| N/A |
| 1 |
| University of Texas Southwestern Medical CenterOTHER |
| 1 |
| Feb 6, 2024 |
| clinicaltrials |
| NCT06004141 | Behavioral Coaching Intervention (Laguna Health) for Patients With Cancer(LAGUNA) | terminated | N/A | 18 | Massachusetts General HospitalOTHER | 1 | Feb 2, 2024 | clinicaltrials |
| NCT00984490 | Metformin Hydrochloride in Treating Women With Stage I or Stage II Breast Cancer That Can Be Removed By Surgery | terminated | N/A | 5 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Feb 1, 2024 | clinicaltrials |
| NCT01956552 | Changes in Phenotype and Genotype of Breast Cancers During the Metastatic Process and Optimization of Therapeutic Targeting (ESOPE) | terminated | N/A | 130 | Institut CurieOTHER | 1 | Jan 31, 2024 | clinicaltrials |
| NCT04336163 | Skin Imaging to Inform Laser Treatments | terminated | N/A | 55 | University of California, IrvineOTHER | 1 | Jan 30, 2024 | clinicaltrials |
| NCT02735109 | Interest of the Confocal Microscope in the Diagnosis of Epidermoid Carcinoma of the Vulva and Their Precursors | terminated | N/A | 10 | Centre Hospitalier Universitaire de NiceOTHER | 1 | Jan 26, 2024 | clinicaltrials |
| NCT04947917 | Axillary Lymph Node Tattoo Marking Study | terminated | N/A | 10 | Dana-Farber Cancer InstituteOTHER | 1 | Jan 23, 2024 | clinicaltrials |
| NCT02722616 | Ultrasound Monitoring of Abdominal Soft Tissue | terminated | N/A | 2 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Jan 18, 2024 | clinicaltrials |
| NCT03397342 | MRI Only Radiation Therapy With CPAP | terminated | N/A | 5 | Albert Einstein College of MedicineOTHER | 1 | Jan 18, 2024 | clinicaltrials |
| NCT03970967 | Alpha Radiation Emitters Device for the Treatment of Newly Diagnosed Breast Carcinoma Patients With Distant Metastases | terminated | N/A | 1 | Alpha Tau Medical LTD.INDUSTRY | 1 | Jan 18, 2024 | clinicaltrials |
| NCT03606486 | Lavage of the Uterine Cavity for Diagnosis of Ovarian Cancer | terminated | N/A | 52 | University of WashingtonOTHER | 1 | Jan 17, 2024 | clinicaltrials |
| NCT00250809 | Scheduled Triple-lumen Central Venous Catheter Exchange: A Prospective Controlled Randomized Study | terminated | N/A | 15 | University of New MexicoOTHER | 1 | Jan 12, 2024 | clinicaltrials |
| NCT02502318 | Medicoeconomic Evaluation of Two Surgical Techniques for Lobectomy in the Lung Cancer(LungSco01) | terminated | N/A | 261 | Centre Hospitalier Universitaire DijonOTHER | 1 | Jan 12, 2024 | clinicaltrials |
| NCT02580981 | Acute Lymphoblastic Leukemia Therapies Informed by Genomic Analyses | terminated | N/A | 21 | New Mexico Cancer Research AllianceOTHER | 1 | Jan 11, 2024 | clinicaltrials |
| NCT03806244 | Feasibility of Stereotactic Navigation in Laparoscopic Surgery for Colorectal Cancer(PELVINAV) | terminated | N/A | 12 | IHU StrasbourgOTHER | 1 | Jan 8, 2024 | clinicaltrials |
| NCT02823262 | A Breast Cancer Treatment Decision Aid for Women Aged 70 and Older | terminated | N/A | 65 | Beth Israel Deaconess Medical CenterOTHER | 1 | Jan 5, 2024 | clinicaltrials |
| NCT03753789 | Ablation Confirmation Study | terminated | N/A | 46 | Ethicon, Inc.INDUSTRY | 1 | Jan 5, 2024 | clinicaltrials |
| NCT02378558 | A Trial of a New Magnetic Breast Marking Clip | terminated | N/A | 3 | Antonios LikourezosOTHER | 1 | Dec 14, 2023 | clinicaltrials |
| NCT04341740 | Investigating Marrow Infiltrating Lymphocytes in Renal Cell Carcinoma(WindMIL-001) | terminated | N/A | 6 | University of OklahomaOTHER | 1 | Dec 13, 2023 | clinicaltrials |
| NCT04452396 | CGM (Continuous Glucose Monitoring) Use in Diagnosis of Spontaneous and Reactive Hypoglycaemia | terminated | N/A | 7 | Barts & The London NHS TrustOTHER | 1 | Dec 12, 2023 | clinicaltrials |
| NCT02802124 | Carbon Ion Radiotherapy for the Treatment of Chinese Hepatocellular Carcinoma | terminated | N/A | 30 | Shanghai Proton and Heavy Ion CenterOTHER | 1 | Dec 7, 2023 | clinicaltrials |
| NCT00869804 | Heading Off Peripheral Neuropathy With Exercise(HOPE) | terminated | N/A | 19 | University of NebraskaOTHER | 1 | Dec 5, 2023 | clinicaltrials |
| NCT04777786 | Early Rehabilitation for Breast Cancer - A Randomized Control Trial | terminated | N/A | 3 | University of South CarolinaOTHER | 1 | Nov 30, 2023 | clinicaltrials |
| NCT03641287 | The Effects of Exercise on Distress, Quality of Life, and Biomarkers in Ovarian Cancer Survivors | terminated | N/A | 64 | University of WashingtonOTHER | 1 | Nov 29, 2023 | clinicaltrials |
| NCT02963363 | Adapted Physical Activity for Breast Cancer HER2 Positive Patient(APACAN2) | terminated | N/A | 36 | Centre Jean PerrinOTHER | 1 | Nov 24, 2023 | clinicaltrials |
| NCT03412630 | Perfusion CT in Predicting Outcomes in Ovarian, Fallopian, or Peritoneal Cancer With Bevacizumab | terminated | N/A | 1 | ECOG-ACRIN Cancer Research GroupNETWORK | 1 | Nov 24, 2023 | clinicaltrials |
| NCT03550040 | 3D Versus Robot Assisted Laparoscopic Prostatectomy. | terminated | N/A | 155 | Tampere University HospitalOTHER | 1 | Nov 24, 2023 | clinicaltrials |
| NCT01931709 | FDG PET and DCE-MRI in Predicting Response to Treatment in Patients With Breast Cancer | terminated | N/A | 35 | University of WashingtonOTHER | 1 | Nov 18, 2023 | clinicaltrials |
| NCT02892487 | Evaluation of an Active Swallowing Rehabilitation on Quality of Life of Patients Treated by Radiotherapy for Head and Neck Cancer(RORC) | terminated | N/A | 183 | Rennes University HospitalOTHER | 1 | Nov 18, 2023 | clinicaltrials |
| NCT05910697 | Clinical Utility of MyProstateScore 2.0 P2 | terminated | N/A | 142 | Qure Healthcare, LLCINDUSTRY | 1 | Nov 15, 2023 | clinicaltrials |
| NCT01901562 | Feasibility and Therapeutic Efficacy of Ductoscopic Papilloma Extraction in Patients With Pathologic Nipple Discharge | terminated | N/A | 9 | Montefiore Medical CenterOTHER | 1 | Nov 9, 2023 | clinicaltrials |
| NCT04763031 | Recurrent GBM With Maximal Neurosurgical Removal and Treatment With IORT | terminated | N/A | 1 | Parkridge Medical CenterOTHER | 1 | Nov 9, 2023 | clinicaltrials |
| NCT04621604 | Evaluation of the Relationship Between Anti-PD-1 Exposure and Tumour VOLUME in Patients Treated for Classical HODgkin's Lymphoma.(REVOLUMHOD) | terminated | N/A | 7 | Rennes University HospitalOTHER | 1 | Oct 31, 2023 | clinicaltrials |
| NCT04249115 | Nano-Pulse Stimulation (NPS) in Seborrheic Keratosis Optimization Study | terminated | N/A | 175 | Pulse Biosciences, Inc.INDUSTRY | 1 | Oct 30, 2023 | clinicaltrials |
| NCT04235660 | Y90 Radiation Segmentectomy vs SBRT for HCC(SBRT vs Y90) | terminated | N/A | 2 | Indiana UniversityOTHER | 1 | Oct 25, 2023 | clinicaltrials |
| NCT01366833 | Optimal Management of Malignant Dysphagia | terminated | N/A | 3 | McGill University Health Centre/Research Institute of the McGill University Health CentreOTHER | 1 | Oct 23, 2023 | clinicaltrials |
| NCT02626377 | Multicenter Prospective Cohort of Informal Caregivers in Burgundy and Franche-Comté(ICE) | terminated | N/A | 186 | Centre Hospitalier Universitaire de BesanconOTHER | 1 | Oct 23, 2023 | clinicaltrials |
| NCT04977401 | EndoscoPic Submucosal dIssection Using geL Versus glycerOl for Submucosal iNjection(EPSILON) | terminated | N/A | 32 | Erasme University HospitalOTHER | 3 | Oct 23, 2023 | clinicaltrials |
| NCT04805203 | Analysis of the Immune Parameters of COVID-19 Infection in Patients With Multiple Myeloma(Covimmunomm) | terminated | N/A | 139 | Intergroupe Francophone du MyelomeNETWORK | 1 | Oct 19, 2023 | clinicaltrials |
| NCT03623490 | Optimizing the Management of Patients With Oral Therapy(IPAC) | terminated | N/A | 101 | Centre Georges Francois LeclercOTHER | 1 | Oct 17, 2023 | clinicaltrials |
| NCT04562233 | Breast Cancer and Resistance Exercise Program(B-REP) | terminated | N/A | 56 | Rutgers, The State University of New JerseyOTHER | 1 | Oct 13, 2023 | clinicaltrials |
| NCT03180398 | Multi-parametric Magnetic Resonance Imaging for Prostate Cancer Patients | terminated | N/A | 9 | Henry Ford Health SystemOTHER | 1 | Oct 12, 2023 | clinicaltrials |
| NCT04040400 | Study of Intraoperative Radiotherapy for Patients With Large Brain Metastases Treated With Neurosurgical Resection | terminated | N/A | 5 | University of LouisvilleOTHER | 1 | Oct 12, 2023 | clinicaltrials |
| NCT02847468 | Multimetabolic 18F-Fluorodeoxyglucose (FDG) and 18F-Fluorocholine (FCH) Positron Emission Tomography (PET) as an Early Predictive Factor of Overall Survival in Patients With Advanced Hepatocellular Carcinoma Treated With Sorafenib(PREMETHEP) | terminated | N/A | 61 | Centre Georges Francois LeclercOTHER | 1 | Oct 11, 2023 | clinicaltrials |
| NCT04040244 | Exhaled Breath Analysis to Predict Risk of Symptomatic Pneumonitis | terminated | N/A | 16 | Wake Forest University Health SciencesOTHER | 1 | Oct 11, 2023 | clinicaltrials |
| NCT04082988 | Early Response Evaluation in NSCLC Patients Treated With Immunotherapy | terminated | N/A | 9 | The Netherlands Cancer InstituteOTHER | 1 | Oct 10, 2023 | clinicaltrials |
| NCT06069453 | Hyaluronic Acid Sodium Salt and Hydeal-D in the Management of LUTS After TURBT for NMIBC. | terminated | N/A | 54 | Fidia Farmaceutici s.p.a.INDUSTRY | 1 | Oct 5, 2023 | clinicaltrials |
| NCT02673021 | MARK 1A Series: Percutaneous Microwave Ablation for Patients With Lung Tumor(s)(MARK 1A) | terminated | N/A | 9 | Mayo ClinicOTHER | 1 | Oct 4, 2023 | clinicaltrials |
Data updated 23 days agoSource updated Feb 13, 2024source: clinicaltrials